SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Sean McCarthy to be a panelist at CED's Business Development Partnering Forum at the NC Biotech Center in Research Triangle Park, NC.
News | 12. 10. 2007
